SUMMARY A sensitive 4 h 51Cr-release cytotoxicity assay has been developed using as targets colonic epithelial cells obtained by Dispase-collagenase digestion of resected mucosa or colonoscopic biopsies. Peripheral blood mononuclear cells (MNC) from most healthy donors showed low, but significant levels of cytotoxicity for normal epithelial cell target cells of 8-7 (4.4) % (mean (SD)) and similar levels were found in 14 ulcerative colitis (6-5 (4.4) %) and 16 Crohn's disease (6.2 (5.2) %) patients. Neither drug therapy nor disease activity influenced the results. The sensitivity of colonic epithelial cells isolated from inflamed and histologically normal mucosa to lysis by peripheral blood MNC from a single donor was not affected by the underlying disease. Anti-epithelial cell activity did not correlate with anti-K562 activity and the cytotoxic cell was plastic non-adherent and Leu-llb. None of 15 MNC populations isolated from mucosa of normal, tumour bearing, or chronically inflamed intestine exhibited significant lysis of colonic epithelial cells despite killing of K562 target cells in 10. Lymphokine activated killer (LAK) cells, generated by interleukin-2 stimulation in vitro of nine intestinal and seven peripheral blood MNC populations, exhibited high levels of lysis of K562 cells but, on every occasion, failed to lyse colonic epithelial cells. These data indicate that spontaneously cytotoxic or LAK cells are unlikely to play a role in the generation of colonic epithelial cell injury by direct cytotoxicity in inflammatory bowel disease.
In ulcerative colitis, colonic epithelial cells exhibit abnormality of cell membrane integrity' and increased turnover2 both of which occur in remission and relapse and appear to be disease specific. [1] [2] [3] These findings suggest chronic injury to colonic epithelial cells is occurring in ulcerative colitis but the underlying mediators of such damage are poorly understood. Postulated mechanisms include spontaneous and lymphokine activated cell mediated cytotoxicity. Peripheral blood mononuclear cells (MNC) from ulcerative colitis and Crohn's disease patients, but phenotype of the effector cell being consistent with that of a natural killer or killer cell. Moreover, intestinal MNC from mucosa affected by inflammatory bowel disease were found to lyse autologous colonic epithelial cells with markedly increased activity compared with controls.' Interpretation of these studies, however, is difficult because of the uncertain viability of the target cells used and questionable validity of the microcytotoxicity assays used. 9 Mononuclear cells from intestinal mucosa can be activated by interleukin-2 (IL-2) to exhibit lymphokine activated killer (LAK) cytotoxicity of 1076 not only NK sensitive and NK resistant cell lines`' but also fresh colon cancer cells and lamina propria fibroblasts. 12 13 The ability of such cells to lyse normal colonic epithelial cells has, however, not been examined. Local IL-2 release in the chronically inflamed mucosa of ulcerative colitis or Crohn's disease appears likely and this may lead to the generation in vitro of LAK cells. Indeed, evidence of local LAK cell induction has been reported in the intestinal mucosa of immunised mice after oral challenge of large doses of antigen'4 and in synovial fluid of patients with active rheumatoid arthritis.'5 Thus, the potential for LAK mediated injury to colonic epithelial cells is present and requires examination.
In the present study, a sensitive and quantitative cytotoxicity assay has been developed using as targets normal colonic epithelial cells which are known to maintain their structure and metabolic activity over the entire assay period. '6 This has allowed a reexamination of the cytotoxic activity of circulating MNC against allogeneic colonic epithelial cells in inflammatory bowel disease and healthy subjects and an assessment of the ability of MNC and LAK cells derived from intestinal mucosa to lyse fresh colonic epithelial cells. The quantitative nature of this assay system has also allowed comparison of the anticolonic epithelial cell with that of the classical NK cell. In addition, the effect of the underlying mucosal disease on the sensitivity to lysis of colonic epithelial cells has been examined.
Methods

PATIENTS AND SPECIMENS
Peripheral blood was taken from 18 healthy subjects and from 30 patients with inflammatory bowel disease of whom 14 had ulcerative colitis and 16 Crohn's disease. Their details are outlined in Table 1 .
Tissue was obtained from surgically resected colon from patients with colorectal carcinoma, diverticular disease, redundant sigmoid loop, ulcerative colitis, and Crohn's ileocolitis. Colonoscopic biopsies were also studied from patients with normal colons and colons affected by colorectal carcinoma, ulcerative colitis, and Crohn's colitis. Diagnoses were made on standard clinical, radiological, and histopathological criteria. Adjacent mucosa was histopathologically examined to determine normality or, if from inflammatory bowel disease patients, to determine whether inflammation was present or not. This was judged by assessment of MNC and polymorphonuclear leucocyte infiltration and by changes of epithelial and crypt morphology.
Only surgically resected colon was used for the isolation of intestinal MNC and details of these A typical colonic epithelial cell population after 5'Cr labelling comprising single cells and partial crypts is shown in Figure 1 .
The erythroleukaemic cell line, K562, which is the standard target cell of classical natural killer activity, was also used as target for some studies and was labelled with "'Cr as previously described. 2" The cells were resuspended in supplemented RPMI at a concentration of 5 x 10' cells/ml.
CYTOTOXICITY ASSAY
Assays were undertaken in U-bottomed 96 well microculture plates. 100 tl of labelled target cells were added to varying numbers of effector cells according to the effector:target (E:T) ratio to be used. These were chosen on the basis of findings of previous studies."`1"2 All MNC populations (stimulated or unstimulated) were tested against K562 at 50:1 and colonic epithelial cells at 200:1 whereas 1-063 Percoll interface cells were used at 25:1 and 100:1 respectively. Other E:T ratios were variably tested (see Results). Each well was made up to a total volume of 200 it. Spontaneous release was determined by incubating target cells in culture medium alone and maximal release'by adding 100 ,ul 5%. Triton-X-100 to the target cells. The plate was incubated at 37°C 5%o CO, 95%O air for four hours after which 100 RI cell free supernatant was aspirated from each well and counted in a gamma counter. The average of six to eight wells for experimental (E) and eight to twelve wells for spontaneous (S) and maximal (M) release were calculated. Cytotoxic activity was expressed as percent specific ''Cr release and was calculated by the following formula:
The spontaneous release expressed as a percentage of maximal release was less than 12% for K562 cells. Spontaneous release during 4 h incubation from colonic epithelial cells from histologically normal mucosa was always less than 8% but was 13 (4) ¾Yo from ulcerative colitis and 8 (3) ¾Yo from Crohn's colitis. A specific release value was considered to represent significant cytotoxicity when it exceeded the mean plus three SD of the spontaneous release levels. These values were 3%O and 4.5/% for K562 and colonic epithelial cells respectively. Mononuclear cells from most healthy subjects significantly lysed colonic epithelial cells (Fig. 2) .
Mononuclear cells from ulcerative colitis or Crohn's disease patients showed similar cytotoxicity to those from healthy subjects. Corticosteroid therapy (Fig.  2) or disease activity (data not shown) appeared unrelated to the level of cytotoxicity. Mononuclear cells from one Crohn's disease and two ulcerative colitis patients were tested against autologous and allogeneic colonic epithelial cells and similar cytotoxicity was seen for each target (data not shown). The results shown in Figure 2 represent the interaction of populations of effector and target cells that come from differing donors. When the effector cell population obtained from a single donor was assayed with epithelial cell targets from different sources, considerable variation in sensitivity of epithelial cells to lysis was seen and similar variability of activity was seen when MNC populations from multiple donors against the same epithelial target cell population were tested (data not shown). In an attempt to determine whether a variability in sensitivity to lysis of epithelial cells may have masked disease related differences of cytotoxic activity, one effector donor (donor 1) was tested on every occasion and the activity of that donor's cells assumed to be relatively constant as previously suggested.2' A 'relative cytotoxicity index' was calculated as the ratio of experimental cytotoxicity to that of donor 1 against the same target cell. As shown in Figure 3 , donor 1 (represented by a relative cytotoxicity index of one) lies in an approximately average position amongst healthy donors. Patients with ulcerative colitis exhibited an index3 that did not differ from normal and that was independent of corticosteroid therapy. For patients with Crohn's disease, the index was significantly less than that of healthy subjects whether comparing with that of all patients (p<0.02) or only of those not on corticosteroids (p<0-05). The difference between healthy subjects and patients with Crohn's disease receiving corticosteroids was not significant. In conclusion, the findings of this study clarify the role of spontaneous and lymphokine activated cell mediated cytotoxicity in the pathogenesis of inflammatory bowel disease. The unstimulated effector cells do not exhibit increased activity in peripheral blood and no evidence of their presence in the mucosal compartment can be found. Further studies of cells isolated from mucosa affected by ulcerative colitis are necessary, however, to confirm such data.
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The target cells from patients with inflammatory bowel disease have similar sensitivity to lysis by MNC and, thus, abnormal injury produced by an apparently normal effector system is unlikely. In addition, colonic epithelial cells appear resistant to lysis by LAK cells generated from circulating or mucosal compartments. Thus, non-MHC restricted cytotoxic cells whether spontaneously active or lymphokine activated are unlikely to play a pathogenic role in producing colonic-epithelial cell injury via direct cytotoxicity in patients with inflammatory bowel disease. 
